SECURITIES AND EXCHANGE COMMISSION
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 31, 2003
(State or Other Jurisdiction of
10210 Genetic Center Drive
San Diego, CA 92121
(Address of Principal Executive Offices)
(Registrants telephone number, including area code)
|Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.|
|Item 12. Results of Operations and Financial Condition.|
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) The following exhibits are furnished with this Current Report:
99.1 Press release dated July 31, 2003
Item 12. Results of Operations and Financial Condition.
On July 31, 2003, Gen-Probe Incorporated issued a press release announcing its financial results for the three months ended June 30, 2003. A copy of this press release is attached hereto as Exhibit 99.1.
In accordance with General Instruction B-6 of Form 8-K, the information furnished pursuant to this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or under the Securities Exchange Act of 1934, as amended, unless Gen-Probe expressly sets forth in such filing that such information is to be considered filed or incorporated by reference therein.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|Date: July 31, 2003||GEN-PROBE INCORPORATED|
|By:||/S/ R. William Bowen|
|R. William Bowen
Vice President, General Counsel and
|99.1||Press Release dated July 31, 2003|